Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -98,333 | -72,409 | -42,920 | -21,682 | -66,394 |
| Depreciation Amortization | 281 | 229 | 146 | 69 | 271 |
| Accounts payable and accrued liabilities | 2,378 | 4,420 | 1,698 | 639 | -180 |
| Other Working Capital | 2,729 | 9,136 | 1,752 | 4,008 | 1,482 |
| Other Operating Activity | 11,794 | 5,799 | 4,305 | 2,099 | 5,325 |
| Operating Cash Flow | $-81,151 | $-52,825 | $-35,019 | $-14,867 | $-59,496 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -481 | -481 | -398 | -185 | -115 |
| Purchase Of Investment | -93,596 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -13 | -13 | -8 | -50 |
| Other Investing Activity | 0 | -13 | -13 | -8 | -50 |
| Investing Cash Flow | $-94,077 | $-494 | $-411 | $-193 | $-165 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 4,000 |
| Debt Repayment | -410 | -294 | -183 | -109 | -425 |
| Common Stock Issued | 491 | 89,180 | 95,428 | 88,763 | 100,302 |
| Common Stock Repurchased | -17 | -13 | -13 | N/A | N/A |
| Other Financing Activity | 88,712 | 0 | -6,287 | 0 | -86 |
| Financing Cash Flow | $88,776 | $88,873 | $88,945 | $88,654 | $103,791 |
| Beginning Cash Position | 124,718 | 124,718 | 124,718 | 124,718 | 80,588 |
| End Cash Position | 38,266 | 160,272 | 178,233 | 198,312 | 124,718 |
| Net Cash Flow | $-86,452 | $35,554 | $53,515 | $73,594 | $44,130 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,151 | -52,825 | -35,019 | -14,867 | -59,496 |
| Capital Expenditure | -481 | -481 | -398 | -185 | -115 |
| Free Cash Flow | -81,632 | -53,306 | -35,417 | -15,052 | -59,611 |